Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2016-06-22 16:42:43
Reporting Period:
Filing Date:
Accepted Time:
2016-06-22 16:42:43
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
816284 Celgene Corp CELG Pharmaceutical Preparations (2834) 222711928
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1232505 J Robert Hugin C/o Celgene Corporation
86 Morris Avenue
Summit NJ 07901
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-06-20 75,000 $100.16 1,122,201 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 490 Indirect 401(k) Plan
Common Stock 9,600 Indirect Children
  1. The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person pursuant to a Rule 10b5-1 plan in multiple transactions at prices ranging from $100.01 to $100.30, inclusive. The reporting person undertakes to provide to Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.